Search

Imfinzi looks flimsy in AstraZeneca's Phase III head and neck cancer study

IMFINZI LOOKS FLIMSY IN ASTRAZENECA'S PHASE III HEAD AND NECK CANCER STUDY

Results of the Phase III EAGLE study leave Merck's Keytruda and Bristol's Opdivo as the dominant players in the space of HNSCC after...

Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More

BIO ROUNDUP: DIY BIOHACKING, PCSK9 DATA, SOLID SETBACK & MORE

Drug prices are top of mind for many patients. Some of them have to cut back on basic needs just to pay for treatments that seem to...

 
 
 
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More

BIO ROUNDUP: MELDONIUM SLIP, KRATOM CRACKDOWN, ZINC FINGERS & MORE

The 2018 Winter Olympics will end soon, and we did not skate through these games without a performance-enhancing drug allegation rearing...

Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others

IMMUNOTHERAPY SAFETY WORRIES HALT CELGENE MYELOMA STUDY, SLOW 5 OTHERS

Amid growing concerns about the safety of a new class of cancer immunotherapy drugs when combined with other therapies to treat blood...